StocksFin Logo
Abiomed, Inc.
Abiomed, Inc. country of incorporation
|
https://www.abiomed.com
|
Mr. Michael Minogue
|
2,003 employees
NASDAQ | Healthcare | Medical Devices
Grifols, S.A.
Grifols, S.A. country of incorporation
|
https://www.grifols.com
|
Mr. Raimon Grifols Roura
|
27,584 employees
NASDAQ | Healthcare | Drug Manufacturers—General
Q223 reported Nov 3, 2022 Reporting Period
$265.92M 7.2% vs. Q222 Revenues Q223
81.62% -0.8% vs. Q222 Gross Profit Margin
39.91% 73.9% vs. Q222 Net Profit Margin
7.81M -87.1% vs. Q222 Free Cash Flow Q223
$2.34 87.2% vs. Q222 EPS Q223
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q223
Q222
Q222 reported Jun 30, 2022 Reporting Period
$1.54B 14.1% vs. Q221 Revenues Q222
37.46% -12.8% vs. Q221 Gross Profit Margin
5.86% -42.2% vs. Q221 Net Profit Margin
88.81M -79.6% vs. Q221 Free Cash Flow Q222
$0.13 -34% vs. Q221 EPS Q222
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q223
Q222
Ratios
As of
Sep 30, 2022
Dec 31, 2021
Quick Ratio
6.82
0.92
Current Ratio
7.93
1.59
Cash Ratio
1.36
0.19
Price to Book
7.24
1.11
Price to Sales
41.92
1.37
Price to Earnings
26.25
37.02